Our findings are evidence that rhein exerts a pancreatic protective effect via the activation of the PI3K/AKT/mTOR signaling pathway and activates inhibition of AMPK in AR42J cells suffering from cerulein; rhein is therefore a potential new compound for the treatment of AP. This evidence concerns the gene MTOR and alkaline phosphatase measurement.